Details for New Drug Application (NDA): 206699
✉ Email this page to a colleague
NDA 206699 describes PARICALCITOL, which is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Lotus Pharm Co Ltd, Marksans Pharma, Rising, Teva Pharms Usa, Accord Hlthcare, Amneal Pharms Co, Caplin, Epic Pharma Llc, Eugia Pharma, Hikma Pharms, Hospira, and Sandoz, and is included in seventeen NDAs. It is available from ten suppliers. Additional details are available on the PARICALCITOL profile page.
The generic ingredient in PARICALCITOL is paricalcitol. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
The generic ingredient in PARICALCITOL is paricalcitol. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
Summary for 206699
| Tradename: | PARICALCITOL |
| Applicant: | Amneal Pharms Co |
| Ingredient: | paricalcitol |
| Patents: | 0 |
Suppliers and Packaging for NDA: 206699
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PARICALCITOL | paricalcitol | SOLUTION;INTRAVENOUS | 206699 | ANDA | Amneal Pharmaceuticals LLC | 70121-1033 | 70121-1033-5 | 25 VIAL, SINGLE-DOSE in 1 CARTON (70121-1033-5) / 1 mL in 1 VIAL, SINGLE-DOSE (70121-1033-1) |
| PARICALCITOL | paricalcitol | SOLUTION;INTRAVENOUS | 206699 | ANDA | Amneal Pharmaceuticals LLC | 70121-1033 | 70121-1033-7 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70121-1033-7) / 1 mL in 1 VIAL, SINGLE-DOSE (70121-1033-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 0.002MG/ML (0.002MG/ML) | ||||
| Approval Date: | Mar 9, 2017 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 0.005MG/ML (0.005MG/ML) | ||||
| Approval Date: | Mar 9, 2017 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 0.01MG/2ML (0.005MG/ML) | ||||
| Approval Date: | Mar 9, 2017 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
